親愛的SAPA會員和朋友，

多年來，美中藥協(xié)通過每年夏季的SAPA健康產(chǎn)業(yè)投資論壇與項(xiàng)目路演(HIFnR)，成功促進(jìn)了初創(chuàng)企業(yè)與知名投資機(jī)構(gòu)間的合作。這一活動作為SAPA的旗艦項(xiàng)目之一，至今已連續(xù)舉辦了六屆，孕育了數(shù)百個互利共贏的合作伙伴關(guān)系，并推動了制藥和生物技術(shù)領(lǐng)域的創(chuàng)業(yè)與商業(yè)合作。

2024年，世界經(jīng)濟(jì)形勢依然動蕩，尤其是在生物醫(yī)藥領(lǐng)域中，資本寒冬尚未過去。業(yè)界資深人士大都以“謹(jǐn)慎的樂觀”定調(diào)2024年生物醫(yī)藥產(chǎn)業(yè)的格局與發(fā)展。在這其中，并購和商務(wù)拓展(BD)交易巨增無疑是動蕩市場的一劑強(qiáng)心針:各大制藥公司開始頻頻出手收購小型生物科技制藥公司，促成的商務(wù)合作創(chuàng)歷史新高。在新的環(huán)境下，投資人和創(chuàng)業(yè)者該采取何種策略投融資？

第七屆SAPA健康產(chǎn)業(yè)投資論壇與項(xiàng)目路演將于6月22日在New Brunswick, N舉行。

-眾星云集:

本次盛會匯集了來自全球多家初創(chuàng)公司和知名投資及商務(wù)拓展公司的眾多經(jīng)驗(yàn)豐富的行業(yè)領(lǐng)導(dǎo)者，包括美國默克、百時(shí)美施貴寶(BMS)、武田(Takeda)、阿斯利康(AstraZeneca)等。重量級演講嘉賓包括紐約證券交易所醫(yī)療健康行業(yè)主管Eric J. Dimise博士、Brii Bioscience創(chuàng)始人兼首席執(zhí)行官Zhi Hong博士等。他們將慷慨分享在創(chuàng)業(yè)和投資趨勢方面的獨(dú)到見解和寶貴經(jīng)驗(yàn)。

-創(chuàng)新遇見資本:

目前，已有約40個項(xiàng)目注冊參與路演。本活動旨在為投資者和企業(yè)家提供交流平臺，并為醫(yī)療健康行業(yè)的新興企業(yè)提供有效的支持和解決方案。

-跟蹤行業(yè)前沿發(fā)展，建立深度伙伴關(guān)系:

本次活動將包括全體會議、爐邊暢談、醫(yī)療創(chuàng)新路演、面對面交流、私人伙伴會議、創(chuàng)業(yè)指導(dǎo)等發(fā)展機(jī)會。

早年注冊將于6月10日截止，活動常規(guī)注冊將于6月19日截止, 我們誠邀觀眾盡早注冊，抓住機(jī)遇，合作共贏。

時(shí)間:

2024年6月22日，上午9:00 - 下午6:30(東部標(biāo)準(zhǔn)時(shí)間)

地點(diǎn):

Hyatt Regency New Brunswick, 2 Albany St, New Brunswick, NJ 08901

本次論壇歡迎觀摩者參與，通過活動跟蹤健康產(chǎn)業(yè)創(chuàng)投趨勢，拓展人脈。觀眾將有機(jī)會聆聽行業(yè)專家見解，了解最新的投資動向和創(chuàng)新項(xiàng)目，并與業(yè)內(nèi)人士進(jìn)行交流。早鳥注冊將于6月10日截止。

VIP門票:通過我們的VIP套餐升級您的活動體驗(yàn)，包括優(yōu)先準(zhǔn)入,合作對接,以及個性化的會議服務(wù)。

折扣日間自助停車:每輛車$10刀

代客泊車:按現(xiàn)行費(fèi)率收取停車費(fèi)

注:具體日程安排和嘉賓請以活動網(wǎng)站為準(zhǔn)

根據(jù)以下鏈接可找到我們 SAPA-HQ 2024 HIFnR 社交媒體工具包:

這個工具包提供了可定制的社交媒體帖子、圖形和其他模板，助您支持并分享對 2024 年 SAPA-HQ HIFnR 會議的熱情。您及您的組織可在社交媒體和 SAPA-HQ 社區(qū)平臺上使用這些信息，共同參與 #SAPA2024HIFnR。

美中醫(yī)藥開發(fā)協(xié)會 成立于1993年，總部設(shè)在美國東部的藥谷-新澤西州。SAPA自成立以來發(fā)展迅速，目前在美國和中國共有七個分會及6000多名會員，是美國最活躍的全國性華人專業(yè)協(xié)會之一。SAPA的會員主要來自美國大中型制藥公司及生物技術(shù)公司。會員的專業(yè)技術(shù)領(lǐng)域涵蓋整個醫(yī)藥產(chǎn)業(yè)研發(fā)和生產(chǎn)的每一個環(huán)節(jié)。在如此龐大的會員數(shù)量和高級科技人才的支持下，SAPA多年來不斷地推動業(yè)界在傳統(tǒng)制藥、生物制藥及仿制藥方面的智慧交流。作為在美注冊的非營利機(jī)構(gòu)，SAPA長期以來得到美國及跨國公司的慷慨贊助和支持。SAPA將一如既往地為制藥行業(yè)提供科技研討、職業(yè)發(fā)展、知識培訓(xùn)、商業(yè)合作和創(chuàng)業(yè)投資的廣闊平臺。

SAPA Healthcare Investment Forum Roadshow

Dear SAPA Members and Friends,

As a global organization for pharmaceutical professionals, the Sino-American Pharmaceutical Professionals Association spares no effort in promoting entrepreneurship, healthcare investment, and business cooperation in pharmaceuticals and biotechnology. Our 7th SAPA Healthcare Investment Forum Roadshow, a flagship event, aims to provide a premium platform for connecting investors and entrepreneurs and offer effective solutions and support to emerging enterprises in the healthcare industry.

In 2024, the global economic landscape remains volatile, particularly in the biopharmaceutical field, where the capital winter persists. Industry veterans describe 2024 with "cautious optimism" regarding the biopharmaceutical industry's structure and development. The surge in mergers and acquisitions and business development (BD) transactions serves as a vital boost to the turbulent market.

The 7th SAPA Healthcare Investment Forum Roadshow will be held on June 22nd at the Hyatt Regency in New Brunswick, NJ.

Event Highlights:

-A Gathering of Industry Leaders: This conference brings together numerous experienced industry leaders from multiple global startups and well-known investment and business development companies, including Merck, BMS, Takeda, AstraZeneca, and more.The keynote speakers include Dr. Eric J. Dimise, Sector Lead of Healthcare Life Sciences, Capital Markets at the New York Stock Exchange, and Dr. Zhi Hong, Founder and CEO of Brii Bioscience. They will generously share their unique insights and valuable experiences in entrepreneurship and investment trends.

-When Innovation Meets Capital:Currently, around 40 projects have registered to participate in the roadshow. This event aims to provide a platform for investors and entrepreneurs to communicate, and to offer effective support and solutions for emerging enterprises in the healthcare industry.

-Tracking Cutting-Edge Industry Developments and Building Deep Partnerships: The event will include plenary sessions, fireside chats, healthcare innovation roadshows, face-to-face exchanges, private partner meetings, entrepreneurship guidance, and other development opportunities.

Early bird registration closes on June 10th. Regular registration closes on June 19. So we warmly invite attendees to register early to seize opportunities and achieve collaborative success.

Event information:

Online Roadshow: June 14, 2024 , 8:00 PM - 9:30 PM (Eastern Standard Time)

Offline Conference and Roadshow: June 22, 2024 , 9:00 AM - 6:30 PM (Eastern Standard Time)

Venue for Offline Conference and Roadshow:

Hyatt Regency New Brunswick, 2 Albany St, New Brunswick, NJ 08901

– Confirmed Speakers Guests –

– Partial List of Roadshow Companies –

– Event Agenda–

Note: For the detailed schedule and guest list, please refer to the event website .

– List of Investor and Companies from 2024 HIFnR –

– Registration Information –

In-person conference registration, click HERE

VIP ticket: Elevate your event experience with our VIP package, which includes priority access to partnering and personalized conference support.

Discounted Daily Self-Parking: $10 per vehicle

Valet Parking: Charged at prevailing rates; individuals responsible for their own parking fees

The online roadshow will be held on Friday, June 14, 2024, from 8:00 PM to 9:30 PM .Please scan the QR code below to register for the Online Roadshow for free:

-Social Media Toolkit-

This toolkit provides customizable social media posts, graphics, and other templates to help you support and share your excitement for the 2024 SAPA HIFnR Conference. You and your organization can use this content on social media and the SAPA- HQ community platform, joining together with #SAPA2024HIFnR.

– About SAPA –

The Sino-American Pharmaceutical Professionals Association was established in 1993 and is headquartered in the center of the pharmaceutical corridor in New Jersey, USA. Since its inception, SAPA rapidly became one of the most active Chinese professional associations in the US with seven chapters and more than 6,000 members

SAPA’s members are primarily from large and mid-sized pharmaceutical and biotech companies in the US, with areas of expertise covering almost every aspect of pharmaceutical research and development as well as production

The organization’s large membership base and superb scientific and technical abilities has allowed SAPA to be a key source for knowledge exchange on the latest developments in the pharmaceutical, biotechnology, and generic drug industries

As a non-profit organization registered in the US, SAPA receives generous sponsorship and support from numerous multinational companies in the US and overseas. SAPA will continue to provide a broad platform for scientific and technical discussion, talent exchange, and training for colleagues in the pharmaceutical industry from the US and China

– Welcome to Join Us –

免責(zé)聲明：此文內(nèi)容為本網(wǎng)站轉(zhuǎn)載企業(yè)宣傳資訊，僅代表作者個人觀點(diǎn)，與本網(wǎng)無關(guān)。僅供讀者參考，并請自行核實(shí)相關(guān)內(nèi)容。